PFIZER ($PFE) posted quarterly earnings results for Q1 2026 on Tuesday, May 5th. The company reported earnings of $0.75 per share, beating estimates of $0.72 by $0.03. The company also reported revenue of $14,451,000,000, beating estimates of $13,922,964,130 by $528,035,870.
You can see Quiver Quantitative's $PFE stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
PFIZER Hedge Fund Activity
We have seen 1,373 institutional investors add shares of PFIZER stock to their portfolio, and 1,384 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 101,068,901 shares (-73.9%) from their portfolio in Q4 2025, for an estimated $2,516,615,634
- NORGES BANK removed 20,119,761 shares (-21.5%) from their portfolio in Q4 2025, for an estimated $500,982,048
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 17,862,459 shares (-96.2%) from their portfolio in Q4 2025, for an estimated $444,775,229
- PACER ADVISORS, INC. removed 17,574,851 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $437,613,789
- MORGAN STANLEY added 14,342,946 shares (+19.2%) to their portfolio in Q4 2025, for an estimated $357,139,355
- BANK OF NEW YORK MELLON CORP added 13,581,757 shares (+38.9%) to their portfolio in Q4 2025, for an estimated $338,185,749
- SUSQUEHANNA INTERNATIONAL GROUP, LLP removed 8,837,922 shares (-70.2%) from their portfolio in Q4 2025, for an estimated $220,064,257
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
PFIZER Government Contracts
We have seen $525,514 of award payments to $PFE over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- PFIZER VACCINES STORAGE AND ROTATION CONTRACT: $410,203
- 4569494415!PROCARDIA XL 30 MG TABLET 100S: $24,723
- 4568572944!NALOXONE 4 MG/10 ML VIAL 10ML: $11,280
- 4568676827!HEXTEND 6%-LACT ELEC BAG 500ML: $11,164
- 4568256080!NALOXONE 4 MG/10 ML VIAL 10ML: $8,460
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
PFIZER Congressional Stock Trading
Members of Congress have traded $PFE stock 5 times in the past 6 months. Of those trades, 2 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $PFE stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 4 times. They made 2 purchases worth up to $30,000 on 02/10, 11/18 and 2 sales worth up to $30,000 on 03/13, 12/19.
- REPRESENTATIVE J. FRENCH HILL sold up to $250,000 on 12/31.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API.
PFIZER Analyst Ratings
Wall Street analysts have issued reports on $PFE in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Guggenheim issued a "Buy" rating on 11/24/2025
To track analyst ratings and price targets for PFIZER, check out Quiver Quantitative's $PFE forecast page.
PFIZER Price Targets
Multiple analysts have issued price targets for $PFE recently. We have seen 11 analysts offer price targets for $PFE in the last 6 months, with a median target of $27.0.
Here are some recent targets:
- Geoff Meacham from Citigroup set a target price of $27.0 on 04/29/2026
- Trung Huynh from RBC Capital set a target price of $25.0 on 04/20/2026
- Jin Zhang from CICC set a target price of $33.0 on 04/16/2026
- Michael Yee from UBS set a target price of $27.0 on 04/13/2026
- Terence Flynn from Morgan Stanley set a target price of $28.0 on 04/10/2026
- Jason Gerberry from B of A Securities set a target price of $26.0 on 04/09/2026
- Vamil Divan from Guggenheim set a target price of $36.0 on 03/24/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
